RET rearrangements are actionable alterations in breast cancer-Reference-Cited by-同舟云学术

RET rearrangements are actionable alterations in breast cancer

Published:2018-11-16 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Paratala Bhavna S.,Chung Jon H.^ORCID,Williams Casey B.,Yilmazel Bahar,Petrosky Whitney,Williams Kirstin,Schrock Alexa B.,Gay Laurie M.,Lee Ellen,Dolfi Sonia C.,Pham Kien,Lin Stephanie,Yao Ming,Kulkarni Atul,DiClemente Frances,Liu Chen,Rodriguez-Rodriguez Lorna,Ganesan Shridar,Ross Jeffrey S.,Ali Siraj M.,Leyland-Jones Brian,Hirshfield Kim M.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-07341-4.pdf

Reference65 articles.

1. Agrawal, N. et al. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676–690 (2014).

2. Wang, R. et al. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J. Clin. Oncol. 30, 4352–4359 (2012).

3. Mulligan, L. M. RET revisited: expanding the oncogenic portfolio. Nat. Rev. Cancer 14, 173–186 (2014).

4. Richardson, D. S., Gujral, T. S., Peng, S., Asa, S. L. & Mulligan, L. M. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins. Cancer Res. 69, 4861–4869 (2009).

5. Drilon, A. et al. Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial. Lancet Oncol. 17, 1653–1660 (2016).

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer;Cancer Letters;2024-11

2. Side Chain Investigation of Imidazopyridazine as a Hinge Binder for Targeting Actionable Mutations of RET Kinase;ACS Medicinal Chemistry Letters;2024-09-03

3. REThinking the role of the RET oncogene in breast cancer;Frontiers in Oncology;2024-08-01

4. Guidelines of the Brazilian Society of Surgical Oncology for anatomopathological, immunohistochemical, and molecular testing in female tumors;Journal of Surgical Oncology;2024-07-22

5. The emerging role of nuclear receptor coactivator 4 in health and disease: a novel bridge between iron metabolism and immunity;Cell Death Discovery;2024-07-03